BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2823729)

  • 1. Placental protein 10 (PP10) in the serum of patients with trophoblastic and nontrophoblastic gynaecological tumours.
    Tiitinen A; Than GN; Iino K; Halila H; Seppälä M
    Arch Gynecol Obstet; 1987; 241(1):43-6. PubMed ID: 2823729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of placental protein 10 (PP10) in women with breast cancer and genital carcinoma and in healthy male and female subjects.
    Würz H; Lüben G; Bohn H
    Arch Gynecol; 1983; 233(4):267-74. PubMed ID: 6660921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta lactoglobulin homologue placental protein 14 (PP14) in serum of patients with trophoblastic disease and non-trophoblastic gynecologic malignancy.
    Than GN; Tatra G; Szabó DG; Csaba IF; Bohn H
    Arch Gynecol Obstet; 1988; 243(3):131-7. PubMed ID: 2844125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating placental proteins (hCG, SP1 and PP5) in trophoblastic disease.
    Lee JN; Salem HT; Chard T; Huang SC; Ouyang PC
    Br J Obstet Gynaecol; 1982 Jan; 89(1):69-72. PubMed ID: 6277363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of placenta-specific tissue protein 12 (PP12) in serum during normal pregnancy and in patients with trophoblastic tumour.
    Than GN; Csaba IF; Szabó DG; Bognár ZJ; Arany A; Bohn H
    Arch Gynecol; 1983; 234(1):39-46. PubMed ID: 6318674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Trophoblastic beta 1-glycoprotein in the blood in trophoblastic tumors].
    Sokolov AV; Zhordaniia KI; Ledian KM
    Med Radiol (Mosk); 1983 Aug; 28(8):25-31. PubMed ID: 6310307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placental proteins (SP1, hCG, PP5) and alpha 2-PAG in trophoblastic diseases.
    Than GN; Bohn H; Csaba IF; Szabó DG; Karg NJ; Göcze P
    Arch Gynecol; 1981; 231(1):33-9. PubMed ID: 6174083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular heterogeneity of hCGbeta--related glycoproteins and the clinical relevance in trophoblastic and non-trophoblastic tumors.
    Nishimura R; Koizumi T; Yokotani T; Taniguchi R; Morisue K; Yoshimura M; Hiranmoy D; Yamaguchi S; Nakagawa T; Hasegawa K; Yasui H
    Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S29-32. PubMed ID: 9833612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new placental protein test for the presence and identification of trophoblastic tumors.
    Tatarinov YS
    Antibiot Chemother (1971); 1978; 22():125-31. PubMed ID: 203222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
    Zhang WY
    Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum ferritin and trophoblastic globulin in genital tumors in women].
    Griaznova IM; Borisenko SA; Markarov OV; Fomina MB; Prokopenko PG; Tatarinov IuS
    Vopr Onkol; 1990; 36(2):181-7. PubMed ID: 2180208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of radioimmunoassay for pregnancy-specific beta1-globulin and its measurement in serum of patients with trophoblastic and non-trophoblastic tumours.
    Tatarinov YS; Sokolov AV
    Int J Cancer; 1977 Feb; 19(2):161-6. PubMed ID: 65339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is pregnancy-associated plasma protein A a tumor marker?
    Bischof P; Rapin CH; Weil A; Herrmann W
    Am J Obstet Gynecol; 1982 Jun; 143(4):379-81. PubMed ID: 6178292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic reliability of simultaneous measurements of beta human chorionic gonadotropin and pregnancy-specific beta-1-glycoprotein in serum of patients with trophoblastic disease.
    Takayama M; Soma H; Isaka K; Okudera K; Ogawa T; Kikuchi K
    Gynecol Obstet Invest; 1987; 23(3):151-6. PubMed ID: 3036671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pregnancy-specific beta-1 glycoprotein (SP1) as a marker for tumors with or without trophoblastic character].
    Ruibal A; Comet R; Alvarez Moro FJ; Lafuerza A; Domenech-Torné FM; Salvador L
    Rev Esp Oncol; 1984; 31(3):427-34. PubMed ID: 6100801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical markers in gynaecological cancer.
    Farrell RJ
    Ir Med J; 1980 Aug; 73(8):285-6. PubMed ID: 6161106
    [No Abstract]   [Full Text] [Related]  

  • 17. Placental protein 10 (PP10) in normal pregnancy and cholestasis of pregnancy.
    Tiitinen A; Laatikainen T; Rutanen EM; Ranta T; Koistinen R; Bohn H; Seppälä M
    Br J Obstet Gynaecol; 1985 Nov; 92(11):1137-40. PubMed ID: 4063230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
    Kohorn EI; Kacinski BM; Stanley ER
    Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum relaxin in patients with invasive mole, choriocarcinoma and persistent trophoblastic disease.
    Seki K; Uesato T; Kato K
    Endocrinol Jpn; 1986 Oct; 33(5):727-33. PubMed ID: 3030714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of RIA kit for measuring pregnancy-specific beta 1 glycoprotein (SP1) and its clinical significance as a tumor marker (author's transl)].
    Tsujino D; Chida R; Sasaki Y; Someya K; Shibata K
    Radioisotopes; 1981 Sep; 30(9):502-4. PubMed ID: 6276932
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.